该前列地尔纳米脂质载体由治疗有效量的前列地尔、固态脂质材料、液态油、乳化剂、PEG修饰的酯类和注射用水组成。
The alprostadil nanometer lipid carrier consists of an effective doses of alprostadil, solid lipid material, liquid oil, emulsifier, PEG modified esters and water for injection.
在NLC给药系统中，药物与载体以及脂质载体之间的相容性是决定NLC的微观和介观结构，载药能力，稳定性等药剂学性质的关键因素。
In NLC drug delivery systems, the compatibility of drug and lipid carriers is the key element to determine the structure of microscopic and mesoscopic, drug-loading capacity and stability.
对固体脂质纳米粒(SLN)作为药物载体的最新研究进展进行了综述，指出SLN在药学领域的广阔发展前景。
The development of the solid lipid nanoparticles (SLN) as a pharmaceutical carrier is reviewed. It is suggested that the SLN has broad prospects in the pharmaceutical field.
方法以硬脂酸为载体采用溶剂乳化法制备水飞蓟素固体脂质纳米粒，并用葡聚糖凝胶层析法测定其包封率。
Method Silymarin SLN was prepared through the solvent-emulsifying method with stearic acid as the carrier, and the encapsulation rate was determined with the Sephdex gel chromatogram.
由两亲性脂质分散在水性环境中自发形成各种几何形态构成的药物输送载体正成为制剂载药系统研究的热点之一。
Various geometric shapes and structures self-assembled of amphiphilic lipids when present in an aqueous environment, as active delivery vehicles, are becoming one of focuses of drug delivery system.
隐形脂质纳米胶囊，其制备方法，及其作为活性成分载体的应用。
Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle (s).
脂质纳米粒子是用生物可降解的脂质制备，故这种载体系统拥有很好的生物相容性和安全性。
The lipid nanoparticles are produced from biodegradable lipids, so this carrier system exhibits an excellent tolerability and safety.
脂质纳米粒子是用生物可降解的脂质制备，故这种载体系统拥有很好的生物相容性和安全性。
The lipid nanoparticles are produced from biodegradable lipids, so this carrier system exhibits an excellent tolerability and safety.
应用推荐